Bio-View Ltd (TLV:BIOV)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
17.10
+0.80 (4.91%)
Mar 6, 2026, 11:33 AM IDT
-49.41%
Market Cap 22.92M
Revenue (ttm) 17.88M
Net Income (ttm) -9.67M
Shares Out 134.01M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 34,570
Average Volume 62,152
Open 17.70
Previous Close 16.30
Day's Range 16.90 - 17.70
52-Week Range 12.90 - 34.30
Beta -0.30
RSI 51.21
Earnings Date Mar 26, 2026

About Bio-View

Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company’s products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH and Karyotype samples in real-time; and Allegro Plus, an automatic imaging system, which identifies var... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1998
Employees 33
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BIOV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.